A Spanish researcher has made a major breakthrough by successfully curing pancreatic cancer in mice, a promising step forward against one of the deadliest and most treatment‑resistant cancers.
Pancreatic tumours are often detected late and quickly develop resistance to therapies, contributing to their poor prognosis.
The study, conducted at the Spanish National Cancer Research Centre (CNIO) and led by Mariano Barbacid, revealed that pancreatic tumours can be eliminated and prevented from returning using a triple‑combination therapy. This approach uses three different medications at once to increase effectiveness.
Although the treatment is still in the animal‑testing stage, experts say results like these are an essential milestone before any potential human trials, with many modern cancer therapies first showing success in mice before moving forward.
In a statement, the authors of the study wrote: “These studies open a way to design new combination therapies that can improve the survival of patients with pancreatic ductal adenocarcinoma.”
